162 related articles for article (PubMed ID: 37806171)
1. Possible role of miRNAs in pheochromocytoma pathology - Signaling pathways interaction.
Elkhawaga SY; Elshafei A; Elkady MA; Yehia AM; Abulsoud AI; Abdelmaksoud NM; Elsakka EGE; Ismail A; Mokhtar MM; El-Mahdy HA; Hegazy M; Elballal MS; Mohammed OA; Abdel-Reheim MA; El-Dakroury WA; Abdel Mageed SS; Elrebehy MA; Shahin RK; Zaki MB; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154856. PubMed ID: 37806171
[TBL] [Abstract][Full Text] [Related]
2. The role of miRNAs in the pheochromocytomas.
Li Z; Yu X; Shen J
Tumour Biol; 2016 Apr; 37(4):4235-9. PubMed ID: 26462836
[TBL] [Abstract][Full Text] [Related]
3. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma: a retrospective study from a single center.
Soares NA; Pacheco MTPF; de Sousa MJRFR; Matos ML; Ferreira SAL
Endocr Regul; 2021 Jan; 55(1):16-21. PubMed ID: 33600666
[No Abstract] [Full Text] [Related]
5. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein L
Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry.
Kuhlen M; Pamporaki C; Kunstreich M; Wudy SA; Hartmann MF; Peitzsch M; Vokuhl C; Seitz G; Kreissl MC; Simon T; Hero B; Frühwald MC; Vorwerk P; Redlich A
Front Endocrinol (Lausanne); 2022; 13():918435. PubMed ID: 35784570
[TBL] [Abstract][Full Text] [Related]
8. Histopathological analysis of spontaneous large necrosis of adrenal pheochromocytoma manifested as acute attacks of alternating hypertension and hypotension: a case report.
Ohara N; Uemura Y; Mezaki N; Kimura K; Kaneko M; Kuwano H; Ebe K; Fujita T; Komeyama T; Usuda H; Yamazaki Y; Maekawa T; Sasano H; Kaneko K; Kamoi K
J Med Case Rep; 2016 Oct; 10(1):279. PubMed ID: 27729064
[TBL] [Abstract][Full Text] [Related]
9. Role of miR-101 in pheochromocytoma patients with SDHD mutation.
Zong L; Meng L; Shi R
Int J Clin Exp Pathol; 2015; 8(2):1545-54. PubMed ID: 25973039
[TBL] [Abstract][Full Text] [Related]
10. From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response.
Elsakka EGE; Elshafei A; Elkady MA; Yehia AM; Abulsoud AI; Shahin RK; Abdelmaksoud NM; Elkhawaga SY; Ismail A; Mokhtar MM; Elrebehy MA; Hegazy M; Elballal MS; Mohammed OA; Abdel-Reheim MA; El-Dakroury WA; Abdel Mageed SS; El-Mahdy HA; Doghish AS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):1957-1969. PubMed ID: 37801146
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
12. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
13. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.
Lai EW; Rodriguez OC; Aventian M; Cromelin C; Fricke ST; Martiniova L; Lubensky IA; Lisanti MP; Picard KL; Powers JF; Tischler AS; Pacak K; Albanese C
Cell Cycle; 2007 Aug; 6(15):1946-50. PubMed ID: 17671425
[TBL] [Abstract][Full Text] [Related]
14. [Pheochromocytoma: update on diagnosis and therapy].
Gruber M; Därr R; Eisenhofer G
Dtsch Med Wochenschr; 2014 Mar; 139(10):486-90. PubMed ID: 24570195
[TBL] [Abstract][Full Text] [Related]
15. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Pacak K
Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
[TBL] [Abstract][Full Text] [Related]
16. [Pheochromocytoma - chromaffin cell tumor].
Szosland K; Kopff B; Lewiński A
Endokrynol Pol; 2006; 57(1):54-62. PubMed ID: 16575763
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma: presentation, diagnosis and treatment.
Reisch N; Peczkowska M; Januszewicz A; Neumann HP
J Hypertens; 2006 Dec; 24(12):2331-9. PubMed ID: 17082709
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of pheochromocytoma.
Gifford RW; Bravo EL; Manger WM
Cardiology; 1985; 72 Suppl 1():126-30. PubMed ID: 2865007
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma associated with a succinate dehydrogenase subunit B mutation: A minireview and a case report.
Rezkallah E; Elsaify A; Martin V; Viva L; Nag S; Green B; Cheesman M; Elsaify W
Endocr Regul; 2023 Jan; 57(1):121-127. PubMed ID: 37285461
[No Abstract] [Full Text] [Related]
20. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
